The role of hepatic 11[b]-hydroxysteroid dehydrogenase type 1 in cholesterol homeostasis

2013 ◽  
pp. 1-1
Author(s):  
Kajal Manwani ◽  
Tak Y Man ◽  
Christopher J Kenyon ◽  
Ruth Andrew ◽  
Karen E Chapman ◽  
...  
1995 ◽  
Vol 55 (5-6) ◽  
pp. 525-532 ◽  
Author(s):  
Matti Poutanen ◽  
Veli Isomaa ◽  
Hellevi Peltoketo ◽  
Reijo Vihko

ChemMedChem ◽  
2011 ◽  
Vol 6 (3) ◽  
pp. 476-487 ◽  
Author(s):  
Alexander Oster ◽  
Tobias Klein ◽  
Claudia Henn ◽  
Ruth Werth ◽  
Sandrine Marchais-Oberwinkler ◽  
...  

2017 ◽  
Vol 58 (1) ◽  
pp. R1-R13 ◽  
Author(s):  
Gillian A Gray ◽  
Christopher I White ◽  
Raphael F P Castellan ◽  
Sara J McSweeney ◽  
Karen E Chapman

Corticosteroids influence the development and function of the heart and its response to injury and pressure overload via actions on glucocorticoid (GR) and mineralocorticoid (MR) receptors. Systemic corticosteroid concentration depends largely on the activity of the hypothalamic–pituitary–adrenal (HPA) axis, but glucocorticoid can also be regenerated from intrinsically inert metabolites by the enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), selectively increasing glucocorticoid levels within cells and tissues. Extensive studies have revealed the roles for glucocorticoid regeneration by 11β-HSD1 in liver, adipose, brain and other tissues, but until recently, there has been little focus on the heart. This article reviews the evidence for glucocorticoid metabolism by 11β-HSD1 in the heart and for a role of 11β-HSD1 activity in determining the myocardial growth and physiological function. We also consider the potential of 11β-HSD1 as a therapeutic target to enhance repair after myocardial infarction and to prevent the development of cardiac remodelling and heart failure.


2015 ◽  
Vol 92 (6) ◽  
Author(s):  
Benjamin B. Green ◽  
David A. Armstrong ◽  
Corina Lesseur ◽  
Alison G. Paquette ◽  
Dylan J. Guerin ◽  
...  

2008 ◽  
Vol 32 (3) ◽  
pp. 343-351 ◽  
Author(s):  
Yong Liu ◽  
Frank Park ◽  
Jennifer L. Pietrusz ◽  
Guangfu Jia ◽  
Ravinder J. Singh ◽  
...  

11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1), which regulates the local level of glucocorticoids, has been suggested to be involved in the development of obesity. A definitive functional role for 11β-HSD1 in adipogenesis, however, remains to be established. We developed 3T3-L1 cell lines stably transfected with a small hairpin RNA (shRNA) targeting 11β-HSD1. A shRNA containing two nucleotide substitutions was used as a control. Silencing of 11β-HSD1 substantially attenuated the accumulation of lipid droplets and the expression of adipogenesis marker genes, which was induced by a mixture containing either corticosterone or dexamethasone. Silencing of 11β-HSD1 increased the concentration of 11-dehydrocorticosterone in the culture supernatant but did not significantly affect the levels of corticosterone or dexamethasone. Translocation of glucocorticoid receptors to the nucleus in response to glucocorticoids was significantly attenuated by silencing 11β-HSD1. The number of cells entering the S phase of the cell cycle following the induction of adipogenesis was significantly reduced by silencing 11β-HSD1. 11β-HSD1 shRNA delivered by lentiviral vectors after the induction of differentiation, however, did not affect the progression of adipogenesis. These results indicate that 11β-HSD1 plays a significant functional role in the initiation of 3T3-L1 adipogenesis and provide new mechanistic insights into the role of 11β-HSD1 in the development of obesity and related diseases.


2004 ◽  
Vol 36 (06) ◽  
pp. 365-369 ◽  
Author(s):  
Z. Hochberg ◽  
M. Friedberg ◽  
L. Yaniv ◽  
T. Bader ◽  
D. Tiosano

2009 ◽  
Vol 301 (1-2) ◽  
pp. 212-215 ◽  
Author(s):  
Yaseen A. Al-Soud ◽  
Emmanuel Bey ◽  
Alexander Oster ◽  
Sandrine Marchais-Oberwinkler ◽  
Ruth Werth ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document